Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Hydroxychloroquine may help delay skin damage in lupus patients.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Most hospitalized COVID-19 patients experienced shortness of breath, dry cough, fever, muscle pain, and fatigue.

Hair loss in a child was an early sign of Crohn's disease.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

Trichoscopy is useful for diagnosing and monitoring male pattern hair loss.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

A woman with a long-term skin condition developed a serious skin cancer that led to her death.

Children with Parry Romberg Syndrome had successful facial fat-grafting surgeries after disease stabilization with no complications.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

A rare lupus case in Bangladesh improved with specific treatment.

A COVID-19 vaccine may trigger severe hair loss in rare cases.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.